It inhibits tumor growth and invasion in cisplatin-resistant human epidermal growth factor receptor-2 (HER2)-positive breast cancer by reversing EMT and inhibiting stemness and invasion [28]. This evidence concerns the gene ERBB2 and breast carcinoma.